no image available Dickens & Co. "Breaking Down Barriers: CMS Considers Easing Restrictions on ESAs for Kidney Disease Patients" "A potential game-changer for those with end-stage renal disease, as CMS weighs the benefits of expanded access to ESAs" Price: 21.00€